• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持南非国家健康保险的卫生技术评估。

Health Technology Assessment in Support of National Health Insurance in South Africa.

机构信息

Cochrane South Africa, South African Medical Research Council, Tygerberg, South Africa.

Mott MacDonald (Better Health Programme South Africa), Pretoria, South Africa.

出版信息

Int J Technol Assess Health Care. 2022 May 6;38(1):e44. doi: 10.1017/S0266462322000265.

DOI:
10.1017/S0266462322000265
PMID:35513309
Abstract

South Africa has embarked on major health policy reform to deliver universal health coverage through the establishment of National Health Insurance (NHI). The aim is to improve access, remove financial barriers to care, and enhance care quality. Health technology assessment (HTA) is explicitly identified in the proposed NHI legislation and will have a prominent role in informing decisions about adoption and access to health interventions and technologies. The specific arrangements and approach to HTA in support of this legislation are yet to be determined. Although there is currently no formal national HTA institution in South Africa, there are several processes in both the public and private healthcare sectors that use elements of HTA to varying extents to inform access and resource allocation decisions. Institutions performing HTAs or related activities in South Africa include the National and Provincial Departments of Health, National Treasury, National Health Laboratory Service, Council for Medical Schemes, medical scheme administrators, managed care organizations, academic or research institutions, clinical societies and associations, pharmaceutical and devices companies, private consultancies, and private sector hospital groups. Existing fragmented HTA processes should coordinate and conform to a standardized, fit-for-purpose process and structure that can usefully inform priority setting under NHI and for other decision makers. This transformation will require comprehensive and inclusive planning with dedicated funding and regulation, and provision of strong oversight mechanisms and leadership.

摘要

南非已着手进行重大的卫生政策改革,通过建立国家健康保险(NHI)来实现全民健康覆盖。其目的是改善可及性、消除获得医疗服务的经济障碍,并提高医疗质量。拟议中的 NHI 立法明确指出卫生技术评估(HTA),并将在告知有关健康干预措施和技术的采用和获得的决策方面发挥重要作用。支持该立法的 HTA 的具体安排和方法尚待确定。尽管南非目前没有正式的国家 HTA 机构,但公共和私营医疗保健部门都有几个流程在不同程度上使用 HTA 的要素来告知准入和资源分配决策。在南非进行 HTA 或相关活动的机构包括国家和省级卫生部、国家财政部、国家卫生实验室服务局、医疗计划理事会、医疗计划管理员、管理式医疗组织、学术或研究机构、临床学会和协会、制药和器械公司、私人咨询公司以及私营部门医院集团。现有的零散 HTA 流程应进行协调并符合标准化、适用目的的流程和结构,以便为 NHI 下的优先事项设定和其他决策者提供有用的信息。这种转变需要全面和包容性的规划,包括专门的资金和法规,并提供强有力的监督机制和领导力。

相似文献

1
Health Technology Assessment in Support of National Health Insurance in South Africa.支持南非国家健康保险的卫生技术评估。
Int J Technol Assess Health Care. 2022 May 6;38(1):e44. doi: 10.1017/S0266462322000265.
2
The role of insurance in the achievement of universal coverage within a developing country context: South Africa as a case study.发展中国家实现全民覆盖背景下的保险作用:以南非为例。
BMC Public Health. 2012;12 Suppl 1(Suppl 1):S5. doi: 10.1186/1471-2458-12-S1-S5. Epub 2012 Jun 22.
3
Institutionalizing Health Technology Assessment in South Africa-An Opportunity in National Health Insurance.将卫生技术评估制度化:南非国家健康保险的机遇。
Health Syst Reform. 2023 Dec 31;9(3):2327098. doi: 10.1080/23288604.2024.2327098. Epub 2024 May 7.
4
Introducing an Ethics Framework for health priority-setting in South Africa on the path to universal health coverage.引入南非卫生优先事项设定的伦理框架,以实现全民健康覆盖。
S Afr Med J. 2022 Mar 2;112(3):240-244.
5
National health insurance reform in South Africa: estimating the implications for demand for private health insurance.南非国家医疗保险改革:私人医疗保险需求影响的估计。
Appl Health Econ Health Policy. 2012 May 1;10(3):189-200. doi: 10.2165/11594830-000000000-00000.
6
Perceptions of and support for national health insurance in South Africa's public and private healthcare sectors.南非公共和私营医疗部门对国家医疗保险的认知与支持
Pan Afr Med J. 2018 Aug 16;30:277. doi: 10.11604/pamj.2018.30.277.14147. eCollection 2018.
7
Medical Insurance Representatives Perceptions on National Health Insurance Primary Healthcare Re-Engineering in South Africa: A Qualitative Study.医疗保险代表对南非国家医疗保险初级卫生保健再造的看法:一项定性研究。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241237044. doi: 10.1177/21501319241237044.
8
Policy context, coherence and disjuncture in the implementation of the Ideal Clinic Realisation and Maintenance programme in the Gauteng and Mpumalanga provinces of South Africa.南非豪登省和姆普马兰加省实施理想诊所实现和维持方案的政策背景、一致性和不连贯性。
Health Res Policy Syst. 2020 Jun 3;18(1):55. doi: 10.1186/s12961-020-00567-z.
9
Public engagement in the development of the National Health Insurance: a study involving patients from a central hospital in South Africa.公众参与国家医疗保险的发展:一项涉及南非一家中心医院患者的研究。
BMC Public Health. 2020 Jul 31;20(1):1191. doi: 10.1186/s12889-020-09270-8.
10
The views of public service managers on the implementation of National Health Insurance in primary care: a case of Johannesburg Health District, Gauteng Province, Republic of South Africa.南非共和国豪登省约翰内斯堡卫生区:基层医疗实施国家健康保险计划中公共服务管理者的观点。
BMC Health Serv Res. 2021 Sep 15;21(1):969. doi: 10.1186/s12913-021-06990-4.

引用本文的文献

1
Health technology assessment capacity to support Zambia's health benefits package reform policy.支持赞比亚医保福利套餐改革政策的卫生技术评估能力。
Int J Technol Assess Health Care. 2025 Feb 28;41(1):e15. doi: 10.1017/S0266462325000030.
2
Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa.南非慢性粒细胞白血病酪氨酸激酶抑制剂治疗策略的成本效益
Front Pharmacol. 2025 Jan 7;15:1511603. doi: 10.3389/fphar.2024.1511603. eCollection 2024.
3
Editorial: Global excellence in health economics: Africa.
社论:全球卫生经济学卓越典范:非洲
Front Public Health. 2024 Sep 27;12:1460357. doi: 10.3389/fpubh.2024.1460357. eCollection 2024.
4
Unleashing the potential: the imperative of political support for health technology assessment in Iran.释放潜力:伊朗政治对卫生技术评估提供支持的必要性。
Health Econ Rev. 2024 Oct 8;14(1):84. doi: 10.1186/s13561-024-00563-x.
5
Unpacking the process of developing South Africa's national drug policy - lessons for universal health coverage.剖析南非国家药物政策的制定过程——全民健康覆盖的经验教训
J Pharm Policy Pract. 2024 Jul 17;17(1):2376349. doi: 10.1080/20523211.2024.2376349. eCollection 2024.
6
A situational and stakeholder analysis of health technology assessment in Zimbabwe.津巴布韦卫生技术评估的情境和利益相关者分析。
Int J Technol Assess Health Care. 2024 Apr 29;40(1):e27. doi: 10.1017/S0266462324000266.
7
Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.探索伊朗卫生技术评估的全貌:利益相关者对需求、需求和供应的看法。
Health Res Policy Syst. 2024 Jan 15;22(1):11. doi: 10.1186/s12961-023-01097-0.
8
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.GRADE 概念 7:将指南推荐与可信基本药物清单联系起来的问题和见解。
J Clin Epidemiol. 2024 Feb;166:111241. doi: 10.1016/j.jclinepi.2023.111241. Epub 2023 Dec 19.
9
The role of Iran's context for the development of health technology assessment: challenges and solutions.伊朗背景在卫生技术评估发展中的作用:挑战与解决方案。
Health Econ Rev. 2023 Apr 20;13(1):23. doi: 10.1186/s13561-023-00438-7.